The demonstration of antagonistic actions of TNF-α in Drosophila and mammalian tumours suggests that the successful use of antitumoural immunity as a cancer therapy may strongly depend on, and must take into consideration, the genetic composition of the tumour. Here, TNF is linked to neoplasm.